← All organizations
Highest phase reached
Phase 3
First clinical trial
May 27, 2022Last known activity
Dec 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 12 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (14)
- NCT06134414Lead sponsorPhase 2Dec 31, 2024
- NCT06687174Lead sponsorPhase 2Dec 31, 2024
- NCT06716970Lead sponsorPhase 3Dec 30, 2024
- NCT06933914Lead sponsorPhase 2/Phase 3Nov 30, 2024
- NCT06932744Lead sponsorPhase 3Aug 30, 2024
- NCT06932471Lead sponsorPhase 3Aug 30, 2024
- NCT06543459Lead sponsorPhase 1Aug 10, 2024
- NCT06050226Lead sponsorPhase 2Jul 6, 2023
- NCT06920836Lead sponsorPhase 2Jun 21, 2023
- NCT05828472Study chairPhase 1Jan 10, 2023
- NCT05828472Lead sponsorPhase 1Jan 10, 2023
- NCT05828485Study chairPhase 1Sep 26, 2022
- NCT05828485Lead sponsorPhase 1Sep 26, 2022
- NCT05642585Lead sponsorPhase 1May 27, 2022
Details
- Last known activity
- Dec 31, 2024